- study data: Global Electrical Heterogeneity and Clinical Outcomes NCT03210883 https://clinicaltrials.gov/ct2/show/NCT03210883
- STATA code for statistical analyses (author Larisa Tereshchenko)
- R code for risk calculators (author Shivangi Kewalramani)
Larisa Tereshchenko, MD, PhD, tereshl@ccf.org Last update: October 7, 2023
- Manuscript #1: See file MI_prep_GEHCO_github.do for preparation and execution of multiple imputations. See file MI_analysis_GEHCO_github.do for analysis using imputed dataset.
- Manuscript #2 (competing risk of MMVT and PVT/VF): see file MMVT_PVTVF_GEHCO_github.do and R code (server.R and ui.R).
- Waks JW, Haq KT, Tompkins C, Rogers AJ, Ehdaie A, Bender A, Minnier J, Dalouk K, Howell S, Peiris A, Raitt M, Narayan SM, Chugh SS, Tereshchenko LG. Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study. Heart Rhythm. 2021 Jun;18(6):977-986. doi: 10.1016/j.hrthm.2021.03.006. Epub 2021 Mar 6. PubMed PMID: 33684549; PubMed Central PMCID: PMC8169548.